Who owns JNJWhat JNJ owns
What JOHNSON & JOHNSON owns
The company's own 13F portfolio · as of 2026-09-30 · long US-listed stakes only — private holdings, bonds and cash are not disclosable on a 13F
$761.7M
disclosed stock portfolio
15
positions
45.3%
in PTGX
Positions, as of 2026-09-30
ordered by filed value · % of book = share of the disclosed stock portfolio · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | PTGXPROTAGONIST THERAPEUTICS INC | 2.4M | $345.1M | 45.3% |
| 2 | NBTXNANOBIOTIX | 5.6M | $175.2M | 23% |
| 3 | MGTXMEIRAGTX HLDGS PLC | 6.6M | $73.1M | 9.6% |
| 4 | RAPPRAPPORT THERAPEUTICS INC | 1.8M | $60.0M | 7.9% |
| 5 | CTNMCONTINEUM THERAPEUTICS INC | 2.0M | $26.6M | 3.5% |
| 6 | CBRSCEREBRAS SYSTEMS INC | 128,649 | $22.9M | 3% |
| 7 | XNCRXENCOR INC | 748,062 | $18.7M | 2.5% |
| 8 | LEGNLEGEND BIOTECH CORP | 814,586 | $16.2M | 2.1% |
| 9 | FATEFATE THERAPEUTICS INC | 3.4M | $8.0M | 1.1% |
| 10 | CVRXCVRX INC | 4.0M | $7.0M | 0.9% |
| 11 | PRCTPROCEPT BIOROBOTICS CORP | 357,939 | $6.5M | 0.9% |
| 12 | NMRANEUMORA THERAPEUTICS INC. | 1.8M | $1.1M | 0.1% |
| 13 | VORVOR BIOPHARMA INC | 53,732 | $1.0M | 0.1% |
| 14 | LABSTANDARD BIOTOOLS INC | 311,967 | $231,043 | 0% |
| 15 | ACETADICET BIO INC | 22,779 | $162,642 | 0% |
Source: SEC Form 13F-HR filed by JOHNSON & JOHNSON (CIK 200406), reporting period 2026-09-30. Values are quarter-end filed marks. Research, not investment advice.